Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment

Clinical trial NCT06505018 · RECRUITING

Trial details

NCT number: NCT06505018
Sponsor: UNICANCER
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Triple-Negative Breast Carcinoma

Start date: 2024-07-25
Primary completion: 2026-09-01
Enrollment: 472

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.